Please Wait.....
Report
Latin America Gene Expression Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Latin America Gene Expression Market Report and Forecast 2024-2032
Latin America Gene Expression Market Size
The global gene expression market was valued at USD 13.3 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing emphasis on genomics research. It is expected to grow at a CAGR of 8.50% during the forecast period of 2024-2032, with the values likely to attain USD 32.4 billion by 2032.
Latin America Gene Expression Market Outlook
- In December 2023 , a cross-sectional survey published in the Lancet reported that respondents in Uruguay had the highest levels of self-reported chronic diseases, accounting for 43.2% of the cases. The rising burden of chronic diseases is expected to drive the market demand in the region.
- One of the major Latin America gene expression market trends is the increased strategic partnerships among the key market players to improve access to advanced genomic technologies. In May 2023, Pfizer, and Thermo Fisher Scientific Inc., entered into a collaboration agreement to boost local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries including Latin America.
- In April 2022, Illumina Inc ., announced the launch of a new Solution Center in Brazil, to address the increasing demand for clinical genomics. Such rapid expansion of genomic testing and gene expression analysis capabilities is anticipated to elevate the market value.
Latin America Gene Expression Market Analysis
The market offers products and services used to study and analyze gene expression including devices for extracting genetic material, amplifying DNA or RNA, and analyzing gene expression patterns. The rising technological advancements leading to enhanced speed, accuracy, and affordability of gene expression analysis coupled with the growing demand for personalized treatment approaches are expected to drive the Latin America gene expression market growth.
Latin America is experiencing a high burden of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In December 2023 , a cross-sectional survey of 4 Latin American countries (Colombia, Mexico, Peru, and Uruguay) published in the Lancet reported that respondents in Uruguay had the highest levels of self-reported chronic diseases, accounting for 43.2% of the cases as compared with approximately 25% in the three other countries. Since gene expression studies are integral for understanding these diseases and developing advanced diagnostic and therapeutic strategies, the Latin America gene expression market demand is expected to witness a surge.
One of the major market trends is the increased strategic partnerships among the key market players to improve access to advanced genomic technologies and impact patient outcomes. For instance, in May 2023, Pfizer and Thermo Fisher Scientific Inc., entered into a collaboration agreement to boost local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries including Latin America. This rising availability and adoption of next-generation sequencing technologies are likely to augment the demand for gene expression analysis tools and technologies, thereby propelling market growth.
The Latin America gene expression market share is also influenced by the growing emphasis on genomics research supported by substantial investments from both the public and private sectors. In April 2022, Illumina Inc ., announced the launch of a new regional Solution Center in Sao Paulo, Brazil, to address the increasing demand and interest for clinical genomics in Latin America. Such rapid expansion of genomic testing and gene expression analysis capabilities is anticipated to elevate the market value.
Latin America Gene Expression Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Process
Sample Collection
Purification
cDNA Synthesis & Conversion
PCR Analysis
Data Analysis & Interpretation
Market Breakup by Application
Clinical Diagnostics
Drug Discovery & Development
Research Activities
Other Applications
Market Breakup by Technique
RNA Expression
Promoter Analysis
Protein Expression & Posttranslational Modification Analysis
Market Breakup by Product
Consumables
Instruments
Services
Market Breakup by End User
Pharmaceutical and biotechnology companies
Diagnostic laboratories
Academic research centers
Market Breakup by Country
Brazil
Argentina
Mexico
Others
Leading Players in the Latin America Gene Expression Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- PerkinElmer
- Illumina, Inc.
- Oxford Gene Technology (OGT) Group
- Luminex Corporation
- QIAGEN
- Affymetrix
- Life Technologies
- Agilent Technologies
- Bio-Rad Laboratories
- GE Healthcare
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Latin America gene expression market forecast outlook for 2024-2032?
The Latin America gene expression market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 10.42% during the forecast period of 2024-2032 and is likely to reach a market value of USD 32.4 billion by 2032.
- What are the major factors aiding the Latin America gene expression market demand?
The growing demand for personalized medicine and precision care is fuelling the demand for the market.
- What are the major Latin America gene expression market trends?
One of the significant trends in the market include increased strategic partnerships among the key market players to improve access to advanced genomic technologies. In May 2023, Pfizer and Thermo Fisher Scientific Inc., entered into a collaboration agreement to boost local access to NGS-based testing in over 30 countries including Latin America.
- What is the market segmentation based on the process?
Based on the process, the market is segmented into sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation.
- What are the applications of the market?
Major applications of gene expression include clinical diagnostics, drug discovery and development, research activities, and other applications.
- What is the market breakup by technique?
By technique, the market is divided into RNA expression, promoter analysis, protein expression and posttranslational modification analysis
- What is the market breakup by product?
By therapeutic area, the market is divided into consumables, instruments, and services.
- What are the major end users of the market?
End users of the market are pharmaceutical and biotechnology companies, diagnostic laboratories, and academic research centers.
- What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
- Who are the key players involved in the Latin America gene expression market?
The key players in the market are PerkinElmer, Illumina, Inc., Oxford Gene Technology (OGT) Group, Luminex Corporation, QIAGEN, Affymetrix, Life Technologies, Agilent Technologies, Bio-Rad Laboratories, and GE Healthcare.
Meta description
The Latin America gene expression market is poised for growth, driven by the expansion of the global market, which was valued at USD 13.3 billion in 2023 and is projected to grow at a CAGR of 10.42% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Gene Expression Market Overview
3.1 Latin America Gene Expression Market Historical Value (2017-2023)
3.2 Latin America Gene Expression Market Forecast Value (2024-2032)
4 Latin America Gene Expression Market Landscape*
4.1 Latin America Gene Expression: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Gene Expression: Product Landscape
4.2.1 Analysis by Process
4.2.2 Analysis by Application
5 Latin America Gene Expression Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Gene Expression Market Segmentation (2017-2032)
6.1 Latin America Gene Expression Market (2017-2032) by Process
6.1.1 Market Overview
6.1.2 Sample Collection
6.1.3 Purification
6.1.4 cDNA Synthesis & Conversion
6.1.5 PCR Analysis
6.1.6 Data Analysis & Interpretation
6.2 Latin America Gene Expression Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Clinical Diagnostics
6.2.3 Drug Discovery & Development
6.2.4 Research Activities
6.2.5 Other Applications
6.3 Latin America Gene Expression Market (2017-2032) by Technique
6.3.1 Market Overview
6.3.2 RNA Expression
6.3.3 Promoter Analysis
6.3.4 Protein Expression & Posttranslational Modification Analysis
6.4 Latin America Gene Expression Market (2017-2032) by Product
6.4.1 Market Overview
6.4.2 Consumables
6.4.3 Instruments
6.4.4 Services
6.5 Latin America Gene Expression Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical and Biotechnology Companies
6.5.3 Diagnostic Laboratories
6.5.4 Academic Research Centers
6.6 Latin America Gene Expression Market (2017-2032) by Country
6.6.1 Market Overview
6.6.2 Brazil
6.6.3 Argentina
6.6.4 Mexico
6.6.5 Others
7 Brazil Gene Expression Market (2017-2032)
7.1 Brazil Gene Expression Market (2017-2032) by Process
7.1.1 Market Overview
7.1.2 Sample Collection
7.1.3 Purification
7.1.4 cDNA Synthesis & Conversion
7.1.5 PCR Analysis
7.1.6 Data Analysis & Interpretation
7.2 Brazil Gene Expression Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Clinical Diagnostics
7.2.3 Drug Discovery & Development
7.2.4 Research Activities
7.2.5 Other Applications
7.3 Brazil Gene Expression Market (2017-2032) by Technique
7.3.1 Market Overview
7.3.2 RNA Expression
7.3.3 Promoter Analysis
7.3.4 Protein Expression & Posttranslational Modification Analysis
7.4 Brazil Gene Expression Market (2017-2032) by Product
7.4.1 Market Overview
7.4.2 Consumables
7.4.3 Instruments
7.4.4 Services
7.5 Brazil Gene Expression Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Pharmaceutical and Biotechnology Companies
7.5.3 Diagnostic laboratories
7.5.4 Academic Research Centers
8 Argentina Gene Expression Market (2017-2032)
8.1 Argentina Gene Expression Market (2017-2032) by Process
8.1.1 Market Overview
8.1.2 Sample Collection
8.1.3 Purification
8.1.4 cDNA Synthesis & Conversion
8.1.5 PCR Analysis
8.1.6 Data Analysis & Interpretation
8.2 Argentina Gene Expression Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Clinical Diagnostics
8.2.3 Drug Discovery & Development
8.2.4 Research Activities
8.2.5 Other Applications
8.3 Argentina Gene Expression Market (2017-2032) by Technique
8.3.1 Market Overview
8.3.2 RNA Expression
8.3.3 Promoter Analysis
8.3.4 Protein Expression & Posttranslational Modification Analysis
8.4 Argentina Gene Expression Market (2017-2032) by Product
8.4.1 Market Overview
8.4.2 Consumables
8.4.3 Instruments
8.4.4 Services
8.5 Argentina Gene Expression Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Pharmaceutical and Biotechnology Companies
8.5.3 Diagnostic Laboratories
8.5.4 Academic Research Centers
9 Mexico Gene Expression Market (2017-2032)
9.1 Mexico Gene Expression Market (2017-2032) by Process
9.1.1 Market Overview
9.1.2 Sample Collection
9.1.3 Purification
9.1.4 cDNA Synthesis & Conversion
9.1.5 PCR Analysis
9.1.6 Data Analysis & Interpretation
9.2 Mexico Gene Expression Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Clinical Diagnostics
9.2.3 Drug Discovery & Development
9.2.4 Research Activities
9.2.5 Other Applications
9.3 Mexico Gene Expression Market (2017-2032) by Technique
9.3.1 Market Overview
9.3.2 RNA Expression
9.3.3 Promoter Analysis
9.3.4 Protein Expression & Posttranslational Modification Analysis
9.4 Mexico Gene Expression Market (2017-2032) by Product
9.4.1 Market Overview
9.4.2 Consumables
9.4.3 Instruments
9.4.4 Services
9.5 Mexico Gene Expression Market (2017-2032) by End User
9.5.1 Market Overview
9.5.2 Pharmaceutical and Biotechnology Companies
9.5.3 Diagnostic Laboratories
9.5.4 Academic Research Centers
10 Regulatory Framework
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 PerkinElmer
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Illumina, Inc.
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Oxford Gene Technology (OGT) Group
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Luminex Corporation
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 QIAGEN
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Affymetrix
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Life Technologies
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Agilent Technologies
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Bio-Rad Laboratories
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 GE Healthcare
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 Latin America Gene Expression Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security